Grand Theravac Life Sciences (nanjing) Co., Ltd.
Clinical trials sponsored by Grand Theravac Life Sciences (nanjing) Co., Ltd., explained in plain language.
-
New injection aims to tame chronic hepatitis b
Disease control Not yet recruitingThis early-stage trial tests an injection called TVAX-028 in adults with chronic hepatitis B. The study checks if the drug is safe and how the body processes it. Participants receive either TVAX-028 with an adjuvant or the adjuvant alone, at different dose levels. The goal is to …
Phase: PHASE1 • Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New shot aims to silence hepatitis b virus in Long-Term patients
Disease control Not yet recruitingThis Phase 3 trial tests an injection called TVAX-008 for people with chronic hepatitis B. About 630 adults who have been on antiviral therapy for at least 6 months will receive either TVAX-008, a placebo, or an active comparator. The goal is to see if the treatment can clear hep…
Phase: PHASE3 • Sponsor: Grand Theravac Life Sciences (Nanjing) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC